申请人:SYMRISE AG
公开号:US20130251730A1
公开(公告)日:2013-09-26
Suggested is a compound of the formula (X)
or any salt of a compound of the formula (X) or any mixture containing or consisting of two or more different compounds of the formula (X), two or more different salts of compounds of the formula (X) or one or more different compounds of the formula (X) and one or more different salts of compounds of the formula (X), wherein for
R1, R2 and R3 independently of one another in every compound of the formula (X) the following applies:
R1 means hydrogen or methyl,
R2 means an organic residue with 5 carbon atoms and one oxygen atom or none and
R3 means an organic residue with 10 carbon atoms and one or more oxygen atoms,
or
R1 and R2 together with the carbon atoms in positions 4 and 5 and the oxygen atom bound to the carbon atom in position 4 form a ring and comprise 5 carbon atoms and one oxygen atom or none, and
R3 means an organic residue with 10 carbon atoms and one or more oxygen atoms,
for use in a method for the prophylaxis and/or treatment of inflammation.